Skip to main content
Caplight Logo









Virage-Viager

Virage-Viager

Private

Last Round

Strategic

Oct 25, 2022

Company Overview

Virage-Viager operates in FinTech and is based in Paris. Its latest recorded funding round was a Strategic round in October 2022.

Virage-Viager is a fintech company that specializes in the development and management of 'Viager Mutualisé', a real estate equity release solution for seniors.

Sector

FinTech

Verticals

Property Investment, Wealth Management, Real Estate Finance, PropTech Services

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Virage-Viager Comparables

Compare Virage-Viager with similar companies based on industry and business-model similarity.

Virage-Viager comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Groupe Renée Costes
85%
Dillan
85%
Monetivia
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Virage-Viager Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicOct 25, 2022
StrategicJan 9, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Virage-Viager Investors

Notable investors and investment history

Virage-Viager investors
InvestorRounds
Matmut InnovationStrategic
PréfonStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 74% MoM.

  • Jun 1, 2025

    Monthly visitors increased 68% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Virage-Viager Filings

Explore SEC and related filing metadata, where available.

Virage-Viager filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Virage-Viager's valuation, stock price, and market status.

Is Virage-Viager a public or private company?

Virage-Viager is a private company.

What is the current stock price of Virage-Viager?

Virage-Viager is a private company, so its shares have no public market price. Caplight tracks Virage-Viager's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Virage-Viager worth (valuation)?

Valuation information for Virage-Viager is not publicly available.

Can I buy Virage-Viager stock?

Virage-Viager shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Virage-Viager's last funding round?

Virage-Viager's most recent funding round was Strategic on October 25, 2022.

Who are the main investors in Virage-Viager?

Key investors in Virage-Viager include Matmut Innovation, Préfon.

Will Virage-Viager IPO soon?

No public IPO plans have been announced for Virage-Viager.

How can I track Virage-Viager secondary market activity?

Caplight tracks bids, offers, and trades in Virage-Viager's shares on secondary markets.

Firmographic Details

HeadquartersParis
Employee Range5
Year Founded2010
Last FundingOct 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?